Equities

Owens & Minor Inc

Owens & Minor Inc

Actions
Health CareHealth Care Equipment & Services
  • Price (USD)24.02
  • Today's Change0.74 / 3.18%
  • Shares traded780.11k
  • 1 Year change280.67%
  • Beta0.2191
Data delayed at least 15 minutes, as of Nov 23 2020 21:10 GMT.
More ▼
Take Action
Take Action
Add this security to watchlist, portfolio, or create an alert to track market movement

Profile data is unavailable for this security.

About the company

Owens & Minor, Inc. is a healthcare solutions company with integrated technologies, products and services. The Company operates through two segments: Global Solutions and Global Products. Global Solutions segment includes its United States distribution, outsourced logistics and value-added services business. Global Products manufactures and sources medical surgical products through its production and kitting operations. Global Solutions segment offers a portfolio of products and services to healthcare providers and manufacturers. Its portfolio of medical and surgical supplies includes products purchased from manufacturers and its own proprietary products. Global Products segment provides medical supplies and solutions for the prevention of healthcare-associated infections across the acute and alternate site channels. Its manufacturing facilities are located in the United States, Thailand, Honduras, Mexico and Ireland.

  • Revenue in USD (TTM)7.98bn
  • Net income in USD32.90m
  • Incorporated1993
  • Employees6.40k
  • Location
    Owens & Minor Inc9120 LOCKWOOD BLVDMECHANICSVILLE 23116United StatesUSA
  • Phone+1 (804) 723-7000
  • Fax+1 (804) 723-7100
  • Websitehttp://www.owens-minor.com/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
GenMark Diagnostics, Inc148.67m-25.21m1.00bn437.00--10.58--6.73-0.4059-0.40592.311.320.99235.6611.15340,205.90-16.82-53.95-21.24-69.2438.7940.59-16.96-84.173.84-2.380.4295--24.4023.546.24---19.20--
Fulgent Genetics Inc135.12m47.71m1.05bn139.0021.495.4119.707.802.022.026.168.020.8761--2.77972,093.5033.13-7.5541.47-7.9869.1655.0637.82-16.57----0.00--52.3591.0592.67--10.09--
Atrion Corporation149.81m32.79m1.07bn616.0032.994.4924.217.1417.7317.7481.03130.190.57641.898.21243,202.9012.6216.1013.2316.9345.2147.3321.8921.615.08--0.0026.061.721.957.275.7310.0415.84
BioLife Solutions Inc41.66m-7.44m1.08bn151.00--5.67--25.93-0.2706-0.27061.735.820.29742.038.00275,874.20-5.31-31.90-5.58-35.4359.2865.20-17.87-57.9813.96--0.00--38.6434.6293.46--31.63--
Heska Corp166.77m-18.59m1.20bn386.00--4.37--7.21-2.23-2.2320.3029.070.54872.947.74432,044.00-6.135.38-6.676.7042.3043.55-11.186.163.79-0.08310.1599---3.756.43-125.04---14.88--
Eargo, Inc.-100.00bn-100.00bn1.33bn184.00---------------0.2403------------------------0.363--5.44--41.56---30.94------
Cardiovascular Systems Inc232.60m-23.53m1.42bn779.00--5.28--6.09-0.6712-0.67126.566.690.83252.007.20298,586.70-8.42-8.25-10.10-10.1979.0880.57-10.12-7.715.61-23.480.0718---4.635.44-10,580.78---28.11--
Inmode Ltd177.92m57.95m1.52bn251.0031.026.5626.118.561.381.384.246.520.76712.2514.96708,852.6024.97--28.77--85.21--32.56--6.80--0.00--56.11--173.32------
Pulmonx Corp33.25m-27.60m1.67bn202.00------50.11-0.8332-0.83321.010.0199------184,722.20--------64.54---83.02--3.05-7.690.9851--62.94---12.04------
Nano-X Imaging Ltd-100.00bn-100.00bn1.70bn27.00--7.02----------5.25----------------------------0.00-------1,081.93------
Owens & Minor, Inc.7.98bn32.90m1.70bn6.40k43.013.2713.020.21330.5387-0.9824131.217.082.296.2811.161,247,605.000.9419-1.051.54-1.7111.5412.170.412-0.35170.70081.860.709---2.20-0.490594.28---5.91-60.19
Axonics Modulation Technologies Inc86.70m-66.32m1.80bn302.00--6.13--20.82-1.96-1.962.497.390.3661.279.32287,079.50-28.00---31.63--58.10---76.49--7.48--0.0665--1,854.74---146.08------
AtriCure Inc.210.13m-45.69m1.84bn730.00--4.40--8.74-1.16-1.165.179.270.33131.888.04287,845.20-7.20-9.38-7.75-10.5672.1772.60-21.74-16.125.85-11.690.1292--14.4716.52-57.86--17.20--
Avanos Medical Inc719.60m13.90m2.00bn4.70k145.541.5534.922.780.28740.287415.0326.970.3991.984.23153,106.400.7708-2.780.8662-3.2854.7755.491.93-9.382.141.460.1615--6.94-16.04-270.16---8.41--
Cantel Medical Corp.1.02bn2.84m2.33bn3.67k817.193.2034.882.300.06770.325424.0417.300.64673.626.88276,927.800.1815.640.20236.4645.5346.850.27996.442.672.470.593111.3110.6612.45-94.98-43.0621.5116.63
Integer Holdings Corp1.13bn72.88m2.36bn8.25k32.641.9215.512.092.202.2034.1437.510.47014.745.41136,984.303.031.693.261.8325.5329.986.453.912.232.430.40500.003.5512.8457.1810.4614.19--
Data as of Nov 23 2020. Currency figures normalised to Owens & Minor Inc's reporting currency: US Dollar USD

Institutional shareholders

40.60%Per cent of shares held by top holders
HolderShares% Held
BlackRock Fund Advisorsas of 30 Sep 20209.00m12.24%
The Vanguard Group, Inc.as of 30 Sep 20204.76m6.47%
Dimensional Fund Advisors LPas of 30 Sep 20204.36m5.93%
Renaissance Technologies LLCas of 30 Sep 20203.06m4.16%
SSgA Funds Management, Inc.as of 30 Sep 20202.47m3.37%
JPMorgan Investment Management, Inc.as of 30 Sep 20201.66m2.25%
Deerfield Management Company LPas of 30 Sep 20201.48m2.01%
Northern Trust Investments, Inc.(Investment Management)as of 30 Sep 20201.10m1.50%
Geode Capital Management LLCas of 30 Sep 20201.01m1.38%
Invesco Capital Management LLCas of 30 Sep 2020956.02k1.30%
More ▼
Data from 30 Sep 2020 - 30 Sep 2020Source: FactSet Research Systems Inc.
The Financial and Risk business of Thomson Reuters is now Refinitiv
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.